Drug Shortages: FDA's Ability to Respond Should Be Strengthened.
Drug Shortages: FDA's Ability to Respond Should Be Strengthened. Testimony before the Committee on Health, Education, Labor, and Pensions, US Senate. US Government Accountability Office. GAO-12-315T (December 15, 2011)
This testimony details the US Food and Drug Administration (FDA) response to drug shortage trends and advocates for the agency to have more leverage with manufacturers to address burgeoning shortages.